The mechanism of action of oral antidiabetic drugs : a review of recent literature

Loading...
Thumbnail Image

Authors

Bosenberg, Liesel H.
Van Zyl, Danie G.

Journal Title

Journal ISSN

Volume Title

Publisher

Health & Medical Publishing Group

Abstract

Type 2 diabetes mellitus (DM) is a disorder that is placing an increasing burden on health service delivery worldwide. Consequently, it has become increasingly important that physicians who treat such patients have a good knowledge of antidiabetic drugs that are currently available or will come onto the market. This article presents an overview of all the major drug classes as well as some information on pharmacokinetics, pharmacodynamics, side-effect profiles and indications for use.

Description

Keywords

Antidiabetic drugs, Oral drugs, Type 2 diabetes mellitus, Physician's knowledge, Drug knowledge, Drug mechanism, Pharmacokinetics, Pharmacodynamics, Side effects, Literature review, Insulin secretagogues, Sulfonylureas, Glibenclamide, Gliclazide, Glipizide, Glimepiride, Rapid-acting prandial insulin, Repaglinide, Nateglinide, Insulin releasers, Insulin sensitisers, Biguanides, Metformin, Thiazolidinediones, Pioglitazone, Rosiglitazone, Glucosidase inhibitors, Acarbose, Incretins, Exendin-4, Liraglutide, Vildagliptin, Sitagliptin, Amylin analogues, Pramlintide, Treatment modalities

Sustainable Development Goals

Citation

Bosenberg, LH & Van Zyl, DG 2008, 'The mechanism of action of oral antidiabetic drugs: a review of recent literature', Journal of Endocrinology, Metabolism and Diabetes of South Africa, vol. 13, no. 3, pp. 80-88. [http://www.hmpg.co.za/journaldetail.php?journalno=9]